ScholarIQanswers from OpenAlex

The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway

PaperCitations, authors & open-access status

The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway have?

ScholarIQcitation count

The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway has 114 citations in the OpenAlex counts ScholarIQ stores.

When was The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway published?

ScholarIQyear

The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway has 2015 year in the ScholarIQ index.

What is the open-access status of The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway?

ScholarIQoa status

The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway has green oa status in the ScholarIQ index.

What is the DOI of The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway?

ScholarIQdoi

The DOI for The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway is on the source record.

What is the PMID of The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway?

ScholarIQpmid

The PMID for The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway is on the source record.

What is the OpenAlex record for The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway?

ScholarIQopenalex

The OpenAlex for The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial